ORPHA:213767

Squamous cell carcinoma of the cervix uteri

Synonyms: Cervical squamous cell carcinoma

Type: Disease
Group: Disorder
Age of onset: Adult
Status: active

Orphadata ships no English definition for this code.

Names in Orphadata languages

12 of 12 languages

Lang	Name	Synonyms
en	Squamous cell carcinoma of the cervix uteri	Cervical squamous cell carcinoma
fr	Carcinome épidermoïde du col de l'utérus	Carcinome épidermoïde cervical
de	Plattenepithelkarzinom der Cervix uteri	Plattenepithelkarzinom des Gebärmutterhalses
es	Carcinoma raro de células escamosas de cuello de útero	Carcinoma cervical de células escamosas
it	Carcinoma a cellule squamose della cervice uterina	Carcinoma cervicale a cellule squamose
nl	Plaveiselcelcarcinoom van cervix uteri	Cervicaal plaveiselcelcarcinoom · Plaveiselcelcarcinoom van baarmoederhals
pt	Carcinoma de células escamosas do colo do útero
pl	Rak płaskonabłonkowy szyjki macicy	= en
cs	Dlaždicobuněčný karcinom hrdla děložního	Cervikální dlaždicobuněčný karcinom
uk	Плоскоклітинний рак шийки матки	Плоскоклітинний рак шийки матки
zh	子宫颈鳞状细胞癌	宫颈鳞状细胞癌
tr	Serviks uteri'nin skuamöz hücreli karsinomu	Servikal skuamöz hücreli karsinom

Cross-references

qualifier = Orphanet mapping relation

Source	Code	Qualifier	ICD relation	Validation
ICD-10	C53.0	BTNT	attributed	validated
ICD-10	C53.1	BTNT	attributed	validated
ICD-10	C53.8	BTNT	attributed	validated
ICD-11	2C77.0	E	specific	validated
MONDO	0006143	E		validated
UMLS	C0279671	E		validated
MedDRA	10041848	E		validated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

Classification

Preferential parent (Orphanet linearisation):

ORPHA:250908Rare neoplastic disease

Parents in the classifications (1):

ORPHA:213761Rare cancer of cervix uteri
rare neoplastic diseases; rare gynecological and obstetric diseases

No children.

Codes that Orphanet moved or referred to this one:

ORPHA:213817OBSOLETE: Papillary carcinoma of the cervix uteri referred to · inactive

Genes

0 direct

Orphanet records no gene directly on this code.

Prevalence and incidence

24 records

Type	Class	Value	Area	Qualification	Validation	Source
Annual incidence	1-9 / 100 000	4.28 / 100 000	Europe	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-5 / 10 000	11.822 / 100 000	Bulgaria	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-5 / 10 000	10.336 / 100 000	Estonia	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-5 / 10 000	11.192 / 100 000	Lithuania	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	4.104 / 100 000	Austria	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	4.67 / 100 000	Belgium	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	5.539 / 100 000	Croatia	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	8.277 / 100 000	Czech Republic	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	1.885 / 100 000	Finland	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	4.871 / 100 000	Germany	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	3.707 / 100 000	Iceland	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	4.204 / 100 000	Ireland	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	3.307 / 100 000	Italy	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	7.362 / 100 000	Latvia	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	1.759 / 100 000	Malta	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	4.756 / 100 000	Norway	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	7.941 / 100 000	Poland	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	5.478 / 100 000	Portugal	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	8.555 / 100 000	Slovakia	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	7.507 / 100 000	Slovenia	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	2.867 / 100 000	Spain	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	2.657 / 100 000	Switzerland	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	3.063 / 100 000	Netherlands	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence	1-9 / 100 000	3.312 / 100 000	United Kingdom	Value and class	Validated	RARECARE surveillance of rare cancers in Europe[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

Sources for this card

Orphanet page: orpha.net/en/disease/detail/213767
This record as JSON: /data/d/213767.json